Gene · 389
Papers2,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| New insights of miRNA molecular mechanisms in breast cancer brain metastasis and therapeutic targets. | Noncoding RNA Res | 2023 | 37818447 | PubTator, text mining | PubMed |
| From imaging to clinical outcome: dual-region CT radiomics predicting FOXM1 expression and prognosis in hepatocellular carcinoma. | Front Oncol | 2023 | 37817774 | PubTator, text mining | PubMed |
| Clinical implications of RAB13 expression in pan-cancer based on multi-databases integrative analysis. | Sci Rep | 2023 | 37803063 | PubTator, text mining | PubMed |
| S100PBP is regulated by mutated KRAS and plays a tumour suppressor role in pancreatic cancer. | Oncogene | 2023 | 37794133 | PubTator, text mining | PubMed |
| Phosphoprotein phosphatase activity positively regulates oligomeric pyrin to trigger inflammasome assembly in phagocytes. | mBio | 2023 | 37787552 | PubTator, text mining | PubMed |
| Learning single-cell perturbation responses using neural optimal transport. | Nat Methods | 2023 | 37770709 | PubTator, text mining | PubMed |
| Emerging Immunotherapy Approaches for Treating Prostate Cancer. | Int J Mol Sci | 2023 | 37762648 | PubTator, text mining | PubMed |
| Role of Rho/MRTF in Aggressive Vemurafenib-Resistant Murine Melanomas and Immune Checkpoint Upregulation. | Int J Mol Sci | 2023 | 37762086 | PubTator, text mining | PubMed |
| The Crosstalk between the EGFR and IFN-γ Pathways and Synergistic Roles in Survival Prediction and Immune Escape in Gliomas. | Brain Sci | 2023 | 37759950 | PubTator, text mining | PubMed |
| Entinostat Enhances the Efficacy of Chemotherapy in Small Cell Lung Cancer Through S-phase Arrest and Decreased Base Excision Repair. | Clin Cancer Res | 2023 | 37725585 | PubTator, text mining | PubMed |
| Colonoscopy Combined with Me-Nbi to Observe the Canceration Characteristics of Colon Polyps and the Correlation of RHOC Protein Expression. | Cell Mol Biol (Noisy-le-grand) | 2023 | 37715435 | PubTator, text mining | PubMed |
| Tumor-associated endothelial cell prognostic risk model and tumor immune environment modulation in liver cancer based on single-cell and bulk RNA sequencing: Experimental verification. | Int Immunopharmacol | 2023 | 37690233 | PubTator, text mining | PubMed |
| The origin of brain malignancies at the blood-brain barrier. | Cell Mol Life Sci | 2023 | 37688612 | PubTator, text mining | PubMed |
| Combined Cardiac and Respiratory Monitoring from a Single Signal: A Case Study Employing the Fantasia Database. | Sensors (Basel) | 2023 | 37687857 | PubTator, text mining | PubMed |
| GeNetOntology: identifying affected gene ontology terms via grouping, scoring, and modeling of gene expression data utilizing biological knowledge-based machine learning. | Front Genet | 2023 | 37671046 | PubTator, text mining | PubMed |
| Metabolic signature and proteasome activity controls synovial migration of CDC42hiCD14+ cells in rheumatoid arthritis. | Front Immunol | 2023 | 37662900 | PubTator, text mining | PubMed |
| EMT induces characteristic changes of Rho GTPases and downstream effectors with a mitosis-specific twist. | Phys Biol | 2023 | 37652025 | PubTator, text mining | PubMed |
| Cell-in-cell: a potential biomarker of prognosis and a novel mechanism of drug resistance in cancer. | Front Oncol | 2023 | 37637068 | PubTator, text mining | PubMed |
| Genomics of deletion 7 and 7q in myeloid neoplasm: from pathogenic culprits to potential synthetic lethal therapeutic targets. | Leukemia | 2023 | 37634012 | PubTator, text mining | PubMed |
| Proteomic Mapping of the Interactome of KRAS Mutants Identifies New Features of RAS Signalling Networks and the Mechanism of Action of Sotorasib. | Cancers (Basel) | 2023 | 37627169 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/389/papers?page=6